Multiple Myeloma Clinical Trial

The Indiana Myeloma Registry

Summary

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male or female patients ≥ 18 years of age at the time of informed consent

Has been diagnosed with or is suspected to have one of the following:

Monoclonal Gammopathy of Undetermined Significance (MGUS)
Smoldering Multiple Myeloma
Multiple Myeloma
Bony or Soft Tissue Plasmacytoma
Primary Amyloidosis

Exclusion Criteria:

< 18 years of age

Have not been diagnosed with one of the following:

Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

2500

Study ID:

NCT03616483

Recruitment Status:

Recruiting

Sponsor:

Indiana University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Indiana University Simon Cancer Center
Indianapolis Indiana, 46202, United States More Info
Rafat Abonour, MD
Contact
317-944-0920
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

2500

Study ID:

NCT03616483

Recruitment Status:

Recruiting

Sponsor:


Indiana University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.